Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 3 3Phase 4 2Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Neuroma, Acoustic 1Fibroma 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Triamcinolone Acetonide × Clear all
NCT03627741 2022-08-25

A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors

Mayo Clinic

Phase 1 Completed
10 enrolled

Fibroma

NCT04658836 2022-08-24

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

Medical University of Vienna

Phase 1 Completed
21 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡